Price (90d)
$27.93Signal Score (90d)
138Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $50.83B | $7.17B | $1.80 |
| 2024 | $57.02B | $6.44B | $1.44 |
| 2023 | $49.77B | $5.17B | $1.12 |
| 2022 | $33.30B | $5.95B | $1.24 |
| 2021 | $25.12B | $7.01B | $1.48 |
Social Signal Score
Earnings
Thu, Oct 22(in 2 months)
Consensus estimate $0.65 per share
Typical surprise +6.6% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Jul 28$0.90 vs $0.89beat
- Tue, Apr 28$0.76 vs $0.75beat
- Tue, Feb 10$0.46 vs $0.42beat
- Wed, Oct 22$0.56 vs $0.54beat
- Tue, Jul 29$0.62 vs $0.50beat
- Wed, Apr 30$0.65 vs $0.61beat
Estimates and results for BCS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from BCS's reported EPS growth of 5.0% a year over 4 years.
- EPS in 5 years
- $2.65
- Implied price
- $26.52
- Return from $28.14
- -1.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $13.19 — -53.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 6 | 8 | 10 | 12 | 14 |
|---|---|---|---|---|---|
| -5.0% | -19.3% | -14.5% | -10.6% | -7.3% | -4.4% |
| 0.0% | -15.0% | -10.0% | -5.9% | -2.4% | 0.7% |
| 5.0% | -10.8% | -5.5% | -1.2% | 2.5% | 5.7% |
| 10.0% | -6.5% | -1.0% | 3.5% | 7.4% | 10.7% |
| 15.0% | -2.3% | 3.5% | 8.2% | 12.3% | 15.8% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (5)
- Newsglobenewswire.com·21h ago·Negative
Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., August 14, 2026. Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the inves…
View source ↗ - Newszacks.com·1d ago·Neutral
Do Options Traders Know Something About Barclays Stock We Don't? Investors need to pay close attention to BCS stock based on the movements in the options market lately.
View source ↗ - News247wallst.com·4d ago·Positive
Zuckerberg Plans to Spend $145 Billion on AI This Year. Barclays Says Major Productivity Gains Remain Elusive Mark Zuckerberg is on track to spend as much as $145 billion on AI infrastructure this year, a figure that would have looked absurd just two years ago.
View source ↗ - Newsprnewswire.com·4d ago·Neutral
Rosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation - BCS NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public. So what: If you purchased Barclays securities you may be entit
View source ↗ - Newsglobenewswire.com·7d ago·Negative
Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, Aug. 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.
View source ↗